Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Syneron Medical Ltd. (ELOS): Craig Drill Capital Boosts Its Stake to 5.17%

Page 1 of 11

Craig Drill Capital‘s stake in Syneron Medical Ltd. (NASDAQ:ELOS) has gone up according to a new 13G filing with the SEC. Managed by Craig A. Drill, the fund’s holding of the stock stood at 160,000 Ordinary Shares at the end of the June quarter and has now climbed to 1.82 million Ordinary Shares or 5.17% of Syneron Medical’s outstanding stock.

Syneron Medical Ltd. (NASDAQ:ELOS) is a company that produces various products for the medical aesthetic industry. Since the beginning of the year, the company’s stock has lost 1.43%. In its financial report for the second quarter of 2016, Syneron Medical disclosed revenue of $74.97 million and EPS of $0.03, compared to revenue of $73.51 million, and a loss per share of $0.01 for the same period of the previous year. Recently, the company announced its preliminary financial results for the third quarter, with it announcing that revenue should reach $70 million-to-$72 million; its complete results are scheduled for release on November 9.



At the end of June, 14 smart money managers from within our database were long Syneron Medical Ltd. (NASDAQ:ELOS), same as a quarter earlier. Among the bullish investors were Richard Mashaal’s RIMA Senvest Management, which held $29.56 million worth of Syneron Medical’s shares, Conan Laughlin’s North Tide Capital, with a position valued at $26.92 million, Stephen Dubois’ Camber Capital Management, Jim Simons’ Renaissance Technologies, and Chuck Royce’s Royce & Associates.

Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Trade (NASDAQ:ELOS) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Craig A. Drill 0 1,822,000 0 1,822,000 1,822,000 5.17%
Craig Drill Capital 0 1,822,000 0 1,822,000 1,822,000 5.17%
Craig Drill Capital 0 1,280,600 0 1,280,600 1,280,600 3.63%
Craig Drill Capital II 0 541,400 0 541,400 541,400 1.53%

Craig A. Drill
Craig A. Drill
Craig Drill Capital

Page 1 of 11 – SEC Filing


Under the Securities Exchange Act of 1934
(Amendment No.)*
Syneron Medical Ltd.
(Name of Issuer)
Ordinary Shares, par value NIS 0.01Per Share
(Title of Class of Securities)
(CUSIP Number)
October 17, 2016
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[_]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[_]  Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Syneron Medical Ltd. (NASDAQ:ELOS)
Trade (NASDAQ:ELOS) Now!
Page 1 of 11

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!